Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 24Lymphoid 12Myeloid 8Plasma cell 4Classical hematology 2

Conditions

Myelodysplastic Syndromes 36Leukemia 33Anemia, Refractory, with Excess of Blasts 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia, Myeloid, Chronic-Phase 25Leukemia, Myeloid, Acute 24Lymphoma 22Leukemia, Myeloid, Accelerated Phase 22Leukemia, Lymphocytic, Chronic, B-Cell 20Myeloproliferative Disorders 18Burkitt Lymphoma 18Lymphoma, Non-Hodgkin 17Lymphoma, Follicular 17Leukemia, Myelomonocytic, Chronic 17Multiple Myeloma 16Lymphoma, Mantle-Cell 16Lymphoma, B-Cell, Marginal Zone 16Hodgkin Disease 16Anemia, Refractory 16Myelodysplastic-Myeloproliferative Diseases 15Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 15Dendritic Cell Sarcoma, Interdigitating 15Congenital Abnormalities 15Recurrence 13Neoplasms, Plasma Cell 13Blast Crisis 13Primary Myelofibrosis 12Waldenstrom Macroglobulinemia 8

Interventions

fludarabine 10Cyclophosphamide 8fludarabine phosphate 7Whole-Body Irradiation 7Tacrolimus 5Mycophenolic Acid 5Melphalan 5Thiotepa 4Peripheral Blood Stem Cell Transplantation 4Busulfan 4AP 1903 reagent 4thymoglobulin 3Sirolimus 3Cord Blood Stem Cell Transplantation 3Alemtuzumab 3Stem Cell Transplantation 2Specimen Handling 2Rituximab 2Platelet Transfusion 2Meropenem 2Cyclosporine 2Biopsy 2Antilymphocyte Serum 2visilizumab 1venetoclax 1trametinib 1ruxolitinib 1regorafenib 1ponatinib 1pertuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Antilymphocyte Serum × Classical hematology × Clear all
NCT00720629 2014-07-18

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Terminated
8 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Graft vs Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Hematologic Neoplasms, Primary Myelofibrosis

NCT00795132 2013-07-30

Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies

University of Utah

Phase 2 Completed
47 enrolled 8 charts
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Chronic Disease, Leukemia, Lymphoma, Neoplasms, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡